CXCL10 and neoplasm: This study highlights how the loss of mature miRNAs in TAMs during tumor progression leads to increased classically activated TAMs, improved CD8 response, and decreased CD8 suppression, which was associated with higher expression of CXCL10, CD86, and CXCL9 in the tumors (5).